Effects of topical dorzolamide on retinal and retrobulbar hemodynamics

Acta Ophthalmologica Scandinavica

Volumn 74, Issue 6, 1996, Pages 569-572

  Harris, Alon ^a,d   Arend, Oliver ^b   Arend, Suzanne ^b   Martin, Bruce ^c  

^a INDIANA UNIVERSITY   (United States)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c INDIANA UNIVERSITY   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbonic anhydrase; Central retinal artery; Intraocular pressure; Ophthalmic artery

Indexed keywords

DORZOLAMIDE; FLUORESCEIN; PLACEBO;

ARTICLE; BLOOD FLOW VELOCITY; CILIARY ARTERY; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; NORMAL HUMAN; OPHTHALMIC ARTERY; OPTIC NERVE; PRIORITY JOURNAL; RETINA ARTERY; RETINA BLOOD FLOW; RETINA MACULA LUTEA; SCANNING LASER OPHTHALMOSCOPY; TOPICAL DRUG ADMINISTRATION; VASCULAR RESISTANCE;

EID: 0030454243     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1996.tb00737.x     Document Type: Article

References (20)

1. Becker B (1954): Decrease in intraocular pressure in man by carbonic anhydrase inhibitor: Diamox. A preliminary report. Am J Ophthalmol 37: 13-15.
2. Brechue WF & Maren TH (1993): pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors. Invest Ophthalmol Vis Sci 34: 2581-2587.
3. Carter CJ. Brooks DE, Doyle DL & Drance SM (1990): Investigations into a vascular etiology for low-tension glaucoma. Ophthalmology 97: 49.
4. Crick RP, Vogel R, Newson RB, Shipley MJ, Blackmore H. Palmer A & Bulpitt CJ (1989): The visual field in chronic simple glaucoma and ocular hypertension; its character, progress, relationship to the level of intraocular pressure and response to treatment. Eye 3: 536.
5. Grunwald JE & Zinn H (1992): The acute effect of oral acetazolamide on macular blood flow. Invest Ophthalmol Vis Sci 33: 504-507.
6. Harris A, Sergott RC, Spaeth GL, Katz JL, Lieb WE, Shoemaker J & Martin BJ (1994): Color Doppler analysis of ocular vessel blood velocity in normal tension glaucoma. Am J Ophthalmol 118: 642-649.
7. Hayreh SS, Revie IHS & Edwards J (1970): Vasogenic origin of visual field defects and optic nerve changes in glaucoma. Br J Ophthalmol 54:461.
8. Hiett JA & Dockter CA (1992): Topical carbonic anhydrase inhibitors: a new perspective in glaucoma therapy. Optom Clin 2: 97-112.
9. Higginbotham E (1989): Topical carbonic anhydrase inhibitors. Ophthalmol Clin North Am 2: 113-130.
10. Higginbotham E (1994): Dorzolamide: a brief overview. Chibret Int J Ophthalmol 10: 50-53.
11. Hofmann HM, Feicht B, Brunner-Ferber E, Lippa E & von-Denffer H: MK-507 (L-671 152) (1991): local tolerance and effectiveness of a new local carbonic anhydrase inhibitor in healthy probands. Fortschr Ophthalmol 88: 513-514.
12. Lippa EA, Carlson LE, Ehinger B, Eriksson LO, Finnstrom K, Holmin C, Nilsson SE, Nyman K, Raitta C & Ringvold A (1992): Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 110: 495-499.
13. Lippa EA, Schuman JS, Higginbotham EJ, Kass MA, Weinreb RN, Skuta GL, Epstein DL, Shaw B, Holder DJ & Deasy DA (1991): MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors. Ophthalmology 98: 308-312.
14. Maren TH (1987): Carbonic anhydrase: General perspectives and advances in glaucoma research. Drug Dev Res 10: 266-276.
15. Maren TH, Wynns C & Wistrand PJ (1993): Chemical properties of carbonic anhydrase IV, the membrane-bound enzyme. Mol Pharmacol 44: 901-905.
16. Sánchez-Thorin J C (1994): Clinical efficacy of a topical carbonic anhydrase inhibitor in open-angle glaucoma. Chibret Int J Ophthalmol. 10:37-41.
17. Snedecor GW & Cochran WG (1980): Statistical Methods, ed. 7. Ames, Iowa State University Press, p. 116.
18. Sugrue MF & O'Neill-Davis L (1991): The effect of cyclooxygenase inhibition on the ocular hypotensive action of topical carbonic anhydrase inhibitors in rabbits. J Ocular Pharmacol 7: 201-211.
19. Tielsch JM, Katz J, Sommer A. Quigley HA & Javitt JC (1995): Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment Arch Ophthalmol 113: 216-221.
20. Wilkerson M, Cyrlin M, Lippa EA, Esposito D, Deasy D, Panebianco D, Fazio R, Yablonski M & Shields MB (1993): Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol 111: 1343-1350.